David Bonderman’s TPG Capital Sells Aptalis For $2.9 Billion To Forest Laboratories

– David Bonderman / Getty – David Bonderman’s giant TPG Capital (formerly Texas Pacific Group) is selling Aptalis, a private company it controls, to pharmaceutical company Forest Laboratories, More...